Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use.
Heidari S, Babor TF, De Castro P, Tort S, Curno M. · 2016
Read Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use. by Heidari S, Babor TF, De Castro P, Tort S, Curno M. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5793986.txt.
Introduction
Heidari and co-authors present the SAGER guidelines for reporting sex and gender in research. Such differences are often skipped in study design and reporting. That gap limits how far findings apply, for women and for men. A panel of 13 experts from nine countries built the guidelines.
The group also surveyed hundreds of editors and scientists and searched policy writing. The guidelines give a full procedure for design, analysis, results, and reading of findings. They aim mainly at authors preparing manuscripts. Editors can also use them as a check at the gate of publication.
Catalog record
| CREATOR | Heidari S, Babor TF, De Castro P, Tort S, Curno M. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use By Shirin Heidari, Thomas F Babor, Paola De Castro, Sera Tort, Mirjam Curno Published in: Research Integrity and Peer Review DOI: 10.1186/s41073-016-0007-6 ABSTRACT Abstract Background Sex and gender differences are often overlooked in research design, study implementation and scientific reporting, as well as in general science communication. This oversight limits the generalizability of research findings and their applicability to clinical practice, in particular for women but also for men. This article describes the rationale for an international set of guidelines to encourage a more systematic approach to the reporting of sex and gender in research across disciplines. Methods A panel of 13 experts representing nine countries developed the guidelines through a series of teleconferences, conference presentations and a 2-day workshop. An internet survey of 716 journal editors, scientists and other members of the international publishing community was conducted as well as a literature search on sex and gender policies in scientific publishing. Results The Sex and Gender Equity in Research (SAGER) guidelines are a comprehensive procedure for reporting of sex and gender information in study design, data analyses, results and interpretation of findings. Conclusions The SAGER guidelines are designed primarily to guide authors in preparing their manuscripts, but they are also useful for editors, as gatekeepers of science, to integrate assessment of sex and gender into all manuscripts as an integral part of the editorial process. Keywords: Sex, Gender, Guidelines, SAGER, Scientific research, Scientific publishing, Gender bias, Equity BACKGROUND Sex and gender are important determinants of health and well-being. Sex refers to a set of biological attributes in humans and animals that are associated with physical and physiological features including chromosomes, gene expression, hormone function and reproductive/sexual anatomy [1]. Sex is usually categorized as female or male, although there is variation in the biological attributes that constitute sex and how those attributes are expressed. Gender refers to the socially constructed roles, behaviours and identities of female, male and gender-diverse people [1]. It influences how people perceive themselves and each other, how they behave and interact and the distribution of power and resources in society. Gender is usually incorrectly conceptualized as a binary (female/male) factor. In reality, there is a spectrum of gender identities and expressions defining how individuals identify themselves and express their gender. A glossary of terms is provided in Appendix 1 to define the meaning of sex, gender and related terms. Sex and gender interactions influence health and well-being in a variety of ways. They both impact environmental and occupational risks, risk-taking behaviours, access to health care, health-seeking behaviour, health care utilization, and perceived experience with health care, and thus disease prevalence and treatment outcome. In addition, it is well-known that pharmacokinetics and pharmacodynamics of pharmaceutical agents differ between sexes, resulting in differential adverse event profiles and further impacting treatment outcomes. Thus, sex and gender are critical determinants of health [2]. Sex and gender bias in the conduct of research Despite recognition of the importance of sex and gender in most areas of research, important knowledge gaps persist owing to the general orientation of scientific attention to one sex or gender category and because of a misconception that disaggregation of sex does not apply to other living organisms that can be classified by sex [3–6]. The gap in the representation of women in studies on human subjects has been well-documented [1]. A review of cardiovascular treatment trials included in Cochrane Reviews reveals that only 27 % of the total trial participants in the 258 clinical trials were women [7]. More importantly, among trials recruiting both men and women, only one third reported a gender-based analysis [8]. More than 79 % of animal studies published in Pain over a 10-year period included male subjects only, and only 4 % studied sex differences [9]. The underrepresentation of women in research can result in adverse consequences. Among the ten prescription pharmaceuticals withdrawn from the US market between 1997 and 2001, eight caused greater harm to women than men [10]. More recently, the US Food and Drug Administration (FDA) issued a safety communication, recommending half a dose of zolpidem for women, due to greater susceptibility to the risks of the drug [11]. Sex- and gender-based analysis, in all of these cases, would have provided sufficient information to guide dosing and applicability of drugs in men and women prior to approval. Failure to conduct sex and gender-based analysis occurs in a range of disciplines. In the field of engineering, lack of consideration of differences in the physiology and anatomy of males and females in developing car seats has resulted in higher risk for whiplash injuries among female car occupants compared with men [12, 13]. Although the term “gender gap” has most often been applied to women, the benefit that sex- and gender-based analysis has for our understanding of men’s health should also be noted. Despite the increasing representation of male and female subjects in research and reporting of sex-specific and gender-specific data, these examples indicate that existing policies have not been enforced [3]. Lack of interest in sex and gender differences may not only be harmful but also present missed opportunities for innovation. Understanding the underlying differences and similarities, exploring applicability, uptake and impact of technological innovations and getting deeper insight into cognitive variability will undoubtedly lead to more innovative approaches and better solutions to meet the needs of society. The role of journal editors and editorial policies Editors play an important role as gatekeepers of science, including the articulation of an ethical framework that influences the conduct of research. With an ever-increasing volume of information being published, concerns over the quality of publications have lead journal editors, publishers and professional associations to implement detailed guidelines. Ethical review procedures are now universally applied in human and animal research, in part because of journal requirements. The impact of journal policies on compliance to mandates has been clearly demonstrated in such diverse areas as clinical trial registration [14] and the reporting of systematic reviews after introduction of PRISMA guidelines [15]. Another illustration is the gradual adoption of the Consolidated Standards of Reporting Trials (CONSORT) statement, which has led to improved reporting of randomized controlled trials [16, 17]. Following CONSORT and PRISMA, many other reporting guidelines have been developed, including the ARRIVE guidelines for animal research [18]. Although policy implementation and enforcement continue to be a critical challenge, journals could play an important role in advancing the quality and transparency of reported data by promoting sex- and gender-specific analysis of research data as a matter of routine. In a 2011 workshop on “Sex-specific reporting of scientific research,” convened by the US Institute of Medicine, a number of key issues were identified that journals and journal editors should address in order to improve gender-sensitive reporting of research [3], including the appropriateness of sex-specific data analyses and the absence of journal policies recommending sex and gender considerations in research design and reporting. On the basis of the available evidence, a committee of the US Institute of Medicine in 2010 recommended that the International Committee of Medical Journal Editors (ICMJE) and other editors adopt a guideline that all papers reporting the results of clinical trials